S&P 500 7,457.69 -1.01% NASDAQ 25,520.24 -1.40% DOW 52,146.42 -0.77% R2K 2,962.22 -0.42% VIX 18.77 +12.19% US 10Y 4.54 -0.61% DXY 100.75 +0.02% GOLD 4,023.00 +0.94% CRUDE 81.77 +3.57%
Next Bullish Trade
Sign in
VEEV

Veeva Systems Inc. NYQ · VEEV

$195.38 -1.99 (-1.01%)
Extended · +1.54σ Grade B
+ Compare Open in Sniper

Price chart

Timeframe
Range
Fundamentals · free Click ▲ earnings markers (daily) for the day's move

Loading…

Latest bar · VEEV

Momentum reads · latest daily bar
Last
$195.38
-1.99 (-1.01%)
Mkt cap
$31.7B
Healthcare
RSI(14)
65.4
neutral
Stochastic %K
86.8
overbought
MFI(14)
78.8
neutral
ADX(14)
27.0
trending

Green means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.

Financial overlay · last 12 quarters

The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.

QuarterRevenue Net incomeOp income FCFNet margin Op margin
2026-04-30 $0.9B $0.3B $0.3B $1.1B 29.6% 30.9%
2026-01-31 $0.8B $0.2B $0.2B $0.1B 29.2% 29.4%
2025-10-31 $0.8B $0.2B $0.2B $0.2B 29.1% 29.7%
2025-07-31 $0.8B $0.2B $0.2B $0.2B 25.4% 24.8%
2025-04-30 $0.8B $0.2B $0.2B $0.9B 30.1% 30.8%
2024-10-31 $nanB $nanB $nanB $nanB nan% nan%

Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.

Compare VEEV vs peers

Line VEEV up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.

Comparing VEEV MSFT×
Sector peers + LLY + UNH + JNJ + MRK + ABBV + PFE
Popular + AAPL + NVDA + AMZN + GOOG + META + TSLA + AVGO
Matchups NVDA · AMD · AVGO · SMCI · MU AAPL · MSFT · GOOG · META · AMZN JPM · GS · MS · BAC · C TSLA · RIVN · LCID · GM · F XOM · CVX · OXY · COP
Verdict
Weighted score 0-100 across 2 tickers · best in green
#2
VEEV
score 33.5
5/5 inputs
Momentum leads at 75 with strong 19.59% one-month gain, but zero growth and sentiment scores destroy overall rank.
value 50growth 0quality 40momentum 75sentiment 0
#1
MSFT
score 66.2
5/5 inputs
Perfect 100 growth score from 23.4% EPS expansion and 100 sentiment with 41.86% upside drive top ranking.
value 50growth 100quality 58momentum 25sentiment 100
VEEV
Veeva Systems Inc.
$195.38
-1.01%
Snapshot
Price 195.38
Day % -1.01
1M % 19.59
3M % 16.51
YTD % -10.98
Market cap 31738171392.0
ADV ($) 610400154.4747314
Beta 0.941
OdysseyHQ zone
Current zone Extended
Dist 21-EMA % 6.06
Dist ATR (σ) 1.54
OdysseyHQ grade B
Confluence 5
Valuation
P/E (ttm) 34.9517
P/E (fwd) 19.47036
P/S 9.561948
EV/EBITDA 23.904
P/B 4.358437
FCF yield 0.0397
PEG 0.87
Growth
Revenue yoy 0.163
EPS yoy 0.146
FCF yoy —
Revenue trend 8Q
Quality
Gross margin 0.75021005
Operating margin 0.30932
Net margin 0.28370002
ROE 0.13934
ROA 0.07298
Debt / Equity 0.01
Interest cov. —
Technicals
RSI(14) 65.4
MACD signal bull
vs 50-DMA 13.91
vs 200-DMA -6.51
vs 52w high -37.08
HV-30 43.5
Sentiment
Analyst rec 1.93103
Target upside 25.19
Insider buy-sell 90d 7
Risk
Short interest 5.0300002
Days to cover 2.49
Next earnings 2026-09-02
Full VEEV dashboard →
MSFT
Microsoft Corporation
$393.82
-1.82%
Snapshot
Price 393.82
Day % -1.82
1M % -0.0
3M % -6.29
YTD % -16.73
Market cap 2925466222592.0
ADV ($) 15501831798.361267
Beta 1.13
OdysseyHQ zone
Current zone Neutral
Dist 21-EMA % 1.16
Dist ATR (σ) 0.37
OdysseyHQ grade —
Confluence 0
Valuation
P/E (ttm) 23.427723
P/E (fwd) 20.324642
P/S 9.191689
EV/EBITDA 16.116
P/B 7.0606165
FCF yield 0.0127
PEG 1.19
Growth
Revenue yoy 0.183
EPS yoy 0.234
FCF yoy —
Revenue trend 8Q
Quality
Gross margin 0.68309
Operating margin 0.46326
Net margin 0.39341998
ROE 0.34013999
ROA 0.14814
Debt / Equity 0.3
Interest cov. 52.84
Technicals
RSI(14) 51.9
MACD signal neutral
vs 50-DMA -1.92
vs 200-DMA -10.36
vs 52w high -29.1
HV-30 34.3
Sentiment
Analyst rec 1.32143
Target upside 41.86
Insider buy-sell 90d 20
Risk
Short interest 1.2
Days to cover 1.84
Next earnings 2026-07-29
Full MSFT dashboard →

Earnings replay · last 20 reports

How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.

DateEPS actual EPS estSurprise Next-day
2026-06-03 2.24 2.14 +4.9% -0.1%
2026-03-04 2.06 1.94 +6.5% +4.0%
2025-11-20 2.04 1.95 +4.5% -9.8%
2025-08-27 1.99 1.90 +4.8% -7.2%
2025-05-28 1.97 1.74 +13.0% +19.0%
2025-03-05 1.74 1.58 +10.1% +7.4%
2024-12-05 1.75 1.58 +10.7% +8.1%
2024-08-28 1.62 1.53 +5.6% +8.9%
2024-05-30 1.50 1.42 +5.3% -10.3%
2024-02-29 1.38 1.30 +6.2% -1.6%
2023-12-06 1.34 1.29 +3.7% -3.0%
2023-08-30 1.21 1.13 +7.3% +8.4%
2023-05-31 0.91 0.80 +13.6% +19.7%
2023-03-01 1.15 1.04 +10.6% +4.5%
2022-12-01 1.13 1.07 +5.3% -8.6%
2022-08-31 1.03 1.01 +1.9% -14.0%
2022-06-01 0.99 0.92 +7.3% +14.7%
2022-03-02 0.90 0.88 +2.0% -16.2%
2021-12-01 0.97 0.88 +10.6% -3.6%
2021-09-01 0.94 0.86 +9.0% -5.4%

Earnings markers are overlaid on the daily price chart above. Click a ▲ marker for that day's move.

Peer comparison · Healthcare

Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.

Ticker ⇅ Mkt cap ⇅ P/E ⇅ Fwd P/E ⇅ P/S ⇅ EV/EBITDA ⇅ P/B ⇅ Gross M ⇅ Rev gr ⇅ EPS gr ⇅ FCF yld ⇅
VEEV ★ $32B 34.6 19.5 9.6 23.9 4.4 75.0% 16.3% 14.6% 3.97%
LLY $1,051B 41.8 26.3 14.6 30.1 33.8 82.8% 55.5% 169.9% 0.87%
UNH $387B 32.1 19.2 0.9 20.2 4.0 18.8% 2.0% 0.7% 4.57%
JNJ $609B 29.4 19.7 6.2 18.4 7.5 68.1% 6.6% -1.0% —
MRK $315B 35.9 13.2 4.8 12.1 6.9 76.7% 4.9% — 4.46%
ABBV $450B 124.8 15.6 7.2 17.2 -67.6 72.0% 12.4% -46.2% 4.63%
PFE $143B 19.1 8.8 2.3 7.6 1.6 74.8% 5.4% -10.1% 8.67%
TMO $198B 29.3 19.5 4.4 21.1 3.8 40.9% 6.2% 11.3% 2.79%

Auto-seeded from sector. Click any ticker to switch.

Ownership

Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.

Top institutional holders

Top-10 concentration: 33.18%

HolderShares% out
Blackrock Inc. 11,558,875 7.12%
Vanguard Portfolio Management LLC 7,376,031 4.54%
Vanguard Capital Management LLC 6,670,318 4.11%
Alliancebernstein L.P. 6,271,098 3.86%
Linonia Partnership LP 4,924,626 3.03%
Principal Financial Group, Inc. 4,141,545 2.55%
State Street Corporation 3,608,655 2.22%
T. Rowe Price Investment Management, 3,405,594 2.10%
Geode Capital Management, LLC 3,312,734 2.04%
FMR, LLC 2,613,526 1.61%

Insider activity · 90d

1 buys / 0 sells · ratio 1.0 · Finnhub

  • Zuppas Eleni Nitsa M 6,541
  • Zuppas Eleni Nitsa M 33,418
  • Van Wagener Brian M 4,906
  • Van Wagener Brian F 9,325 @ $184.22
  • Van Wagener Brian M 10,018
  • Schwenger Thomas D. M 8,721
  • Schwenger Thomas D. F 25,449 @ $184.22
  • Schwenger Thomas D. M 26,566
  • Kondath Vipin M 502
  • Kondath Vipin F 2,783 @ $184.22

Analyst estimates

Finnhub

What Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.

Low
$165.0
Mean
$244.59259
High
$350.0
Analysts
27
Recommendation distribution · period 2026-07-01
8
17
9
1
Revision trend (2026-04-01 → 2026-07-01): net 28 → 24 -4 (net = strong_buy+buy − sell−strong_sell)

SEC filings

The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.

FormFiled DescriptionAction
4 2026-07-06 FORM 4 view ·
4 2026-07-06 FORM 4 view ·
4 2026-07-06 FORM 4 view ·
4 2026-07-06 FORM 4 view ·
4 2026-07-06 FORM 4 view ·
4 2026-06-22 FORM 4 view ·
4 2026-06-22 FORM 4 view ·
4 2026-06-22 FORM 4 view ·
4 2026-06-22 FORM 4 view ·
4 2026-06-22 FORM 4 view ·
4 2026-06-22 FORM 4 view ·
4 2026-06-22 FORM 4 view ·
4 2026-06-22 FORM 4 view ·
8-K 2026-06-18 8-K view ·
10-Q 2026-06-05 10-Q view ·
4 2026-06-03 FORM 4 view ·
4 2026-06-03 FORM 4 view ·
4 2026-06-03 FORM 4 view ·
4 2026-06-03 FORM 4 view ·
4 2026-06-03 FORM 4 view ·
4 2026-06-03 FORM 4 view ·
4 2026-06-03 FORM 4 view ·
4 2026-06-03 FORM 4 view ·
8-K 2026-06-03 8-K view ·
4 2026-05-04 FORM 4 view ·
DEF 14A 2026-05-04 DEF 14A view ·
8-K 2026-04-20 8-K view ·
4 2026-04-14 FORM 4 view ·
4 2026-04-09 FORM 4 view ·
4 2026-04-09 FORM 4 view ·
4 2026-04-09 FORM 4 view ·
4 2026-04-09 FORM 4 view ·
4 2026-04-09 FORM 4 view ·
4 2026-04-03 FORM 4 view ·
4 2026-04-03 FORM 4 view ·
4 2026-04-03 FORM 4 view ·
4 2026-04-03 FORM 4 view ·
4 2026-04-03 FORM 4 view ·
10-K 2026-03-20 10-K view ·
4 2026-03-09 FORM 4 view ·
8-K 2026-03-04 8-K view ·
4 2026-03-03 FORM 4 view ·
4 2026-03-03 FORM 4 view ·
4 2026-03-03 FORM 4 view ·
4 2026-03-03 FORM 4 view ·
4 2026-03-03 FORM 4 view ·
4 2026-03-03 FORM 4 view ·
4 2026-03-03 FORM 4 view ·
4 2026-03-03 FORM 4 view ·
4 2026-01-15 FORM 4 view ·
4 2026-01-05 FORM 4 view ·
4 2026-01-05 FORM 4 view ·
4 2026-01-05 FORM 4 view ·
4 2026-01-05 FORM 4 view ·
4 2026-01-05 FORM 4 view ·
8-K 2026-01-05 8-K view ·
4 2025-12-11 FORM 4 view ·
8-K 2025-12-11 8-K view ·
4 2025-12-03 FORM 4 view ·
4 2025-12-02 FORM 4 view ·

About VEEV

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud, such as Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics. In addition, the company offers Veeva Development Cloud consisting of Veeva Clinical Platform, which advances clinical trial execution; Veeva Clinical Data Management that helps sponsors and CROs design and run trials; Veeva Safety, which unifies systems and processes; Veeva RIM that provides regulatory information management capabilities, as well as Veeva Quality Cloud, which i…

Options picks · VEEV

ITM + OTM ideas from the latest scan

Loading…

Congress trades · VEEV

STOCK Act disclosures

Loading…

SEC filings & insiders · VEEV

EDGAR · live

Loading…

Holders · VEEV

Institutions & insider activity

Loading…